Summary
Bristol-Myers Squibb (BMY) has filed an 8-K report on July 23, 2015, to announce its second-quarter 2015 financial results. The filing primarily serves to furnish the press release containing these results and additional supplemental information available on the company's website. Investors should refer to the provided press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) for detailed financial performance, operational updates, and forward-looking statements for the period ending July 22, 2015. While the 8-K itself does not contain the financial figures, it acts as the official notification mechanism for the release of this crucial information. Investors are encouraged to review the exhibits to understand the company's performance in Q2 2015, including revenue, earnings, and any key developments that may impact the company's trajectory. This filing is essential for assessing the company's financial health and strategic progress during the second quarter.
Key Highlights
- 1Bristol-Myers Squibb (BMY) announced its second-quarter 2015 financial results on July 23, 2015.
- 2The 8-K filing includes a press release detailing the Q2 2015 financial performance.
- 3Supplemental financial information is also provided on the company's website and incorporated by reference.
- 4Investors should consult Exhibit 99.1 (press release) and Exhibit 99.2 (supplemental information) for detailed results.
- 5The filing is dated July 23, 2015, with an event date of July 22, 2015.
- 6This report is primarily for the dissemination of financial results and related information.